As further evidence that the NLRP3 inflammasome is activated in MDS, neutralization of S100A9, inhibition of NLRP3, and elimination of Caspase-1 all have been shown to suppress pyroptosis and improve the hematopoietic failure seen in MDS [68]. This evidence concerns the gene CASP1 and myelodysplastic syndrome.